Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Thumbnail

Aidoc’s AI solution for LVOs gains FDA clearance

Aidoc announced Monday, Jan. 13, that its AI solution for detecting large-vessel occlusions (LVOs) in head CTA examinations has gained FDA clearance.

Thumbnail

What can patents teach us about the potential impact of AI?

Researchers have found a new way to predict AI’s impact on the U.S. workforce: paying close attention to patents.

Thumbnail

Effective AI: Deep learning able to differentiate small solid renal masses

Deep learning could potentially assist healthcare providers with the evaluation of small renal masses detected on certain contrast-enhanced CT exams, according to a new study published in the American Journal of Roentgenology.

Thumbnail

Machine learning use in healthcare still limited to proof-of-concept studies

Machine learning (ML) technology has gained popularity in recent years, but its use in healthcare remains largely limited to proof-of-concept academic studies, according to a new study published in Artificial Intelligence in Medicine.

Thumbnail

AI diagnoses prostate cancer as well as pathologists

Researchers have developed a deep learning system capable of evaluating tissue samples and diagnosing prostate cancer at a level comparable with many pathologists.

Thumbnail

4 limitations of blockchain technology every imaging researcher should know

Anyone looking to learn more about blockchain should keep these limitations in mind at all times.

Thumbnail

3 key differences between the diagnostic reasoning of humans and AI

The use of AI in healthcare is rapidly rising, but healthcare providers remain an absolutely essential part of patient care, according to a new analysis published in CMAJ.

Thumbnail

AI can predict patient responses to common antidepressants

Machine learning can play a key role in planning treatment for patients diagnosed with major depressive disorder (MDD), according to new research published in JAMA Network Open.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”